Terms of Service

By clicking a sign-in, sign-up, or acceptance button, creating an account, placing an order, or otherwise accessing or using Aduvera, you agree to these Terms and to Aduvera's Privacy Policy.

Aduvera's contract stack is incorporated by reference:

• These Terms and the Privacy Policy apply to all users of the site and workspace.
• The Data Processing Addendum applies where Aduvera processes personal data on behalf of a customer.
• The Business Associate Addendum applies automatically where HIPAA requires a business associate agreement and Aduvera creates, receives, maintains, or transmits PHI on Customer's behalf.

By accepting these Terms, you accept the DPA and BAA where they apply. If you use the service on behalf of an organization, you represent that you have authority to bind that organization to these Terms and the incorporated addenda.

Aduvera is offered for business and professional use. You may use the service only if you can form a binding contract and, if acting for an organization, have authority to bind that organization. You are responsible for account credentials, all activity under your account, and promptly notifying Aduvera of suspected unauthorized use.

Aduvera provides AI-assisted workflows for clinical documentation and literature research, including transcription, draft note generation, transcript-backed citation review, evidence-search conversations, source retrieval, and related features.

Unless Aduvera expressly states otherwise in writing for a specific regulated module, the service is offered as an assistive documentation and research tool, not as a cleared or approved medical device. Aduvera does not provide medical advice and does not replace clinical judgment, diagnosis, treatment decisions, patient consent processes, or final chart review.

Customers and users are responsible for reviewing all outputs before relying on them, placing them into a medical record, or providing them to a patient or third party.

Aduvera's literature and evidence features are designed to help users locate, summarize, and organize information from public biomedical and regulatory sources. Those features may use sources such as Europe PMC, PubMed, Crossref, OpenAlex, openFDA, and linked journal, guideline, or reference destinations.

Evidence-search outputs are not exhaustive, may omit relevant studies or current guidance, may summarize third-party material imperfectly, and may reflect source outages, indexing delays, ranking choices, or stale information. Aduvera does not promise that literature results are complete, current, licensed for full-text reuse, or suitable as the sole basis for any clinical, prescribing, coding, billing, or utilization-management decision.

You must verify the underlying sources, dates, and current product labeling or clinical guidance before relying on an evidence answer. Do not use the literature workflow for emergency, triage, or other time-critical decisions where delay, outage, or incomplete retrieval could create risk.

• You are responsible for the legality, accuracy, quality, and origin of data submitted to the service.
• You must provide all notices, obtain all consents, and maintain all lawful bases required to record, upload, or process personal data, patient data, or workforce data.
• You must use the service only in compliance with applicable law, professional obligations, payer rules, licensing requirements, and organizational policy.
• You must review and verify outputs before using them in a chart, patient communication, referral, claim, authorization, compliance workflow, or clinical recommendation.
• You should avoid submitting unnecessary direct identifiers, especially when using literature or evidence-search features that may transmit question text or derived search queries to public research or regulatory sources.
• You must not use the service to violate privacy, confidentiality, intellectual-property, export-control, sanctions, anti-corruption, or security laws.

You may not, and may not permit others to:

• reverse engineer, decompile, or attempt to derive source code except where law permits;
• probe, scan, or test the vulnerability of the service without authorization;
• circumvent access controls, rate limits, or account boundaries;
• use the service to build a competing product or benchmark it publicly without permission;
• upload malicious code, unlawful content, or content you do not have rights to process;
• use the service as an autonomous diagnostic, treatment, prescribing, or emergency-response system without meaningful professional review;
• intentionally include unnecessary direct patient identifiers in evidence-search prompts destined for public biomedical or regulatory sources.

Aduvera processes personal data as described in the Privacy Policy and, where applicable, the Data Processing Addendum ("DPA") and Business Associate Addendum ("BAA"), each of which is incorporated into these Terms by reference.

If Customer is a covered entity or business associate under HIPAA and Aduvera creates, receives, maintains, or transmits Protected Health Information ("PHI") on Customer's behalf, the BAA applies automatically to that HIPAA-covered workflow. The BAA governs permitted PHI uses and disclosures, safeguards, breach and incident terms, subcontractor obligations, and return or deletion of PHI.

If applicable data protection laws, including GDPR or UK GDPR, require a data processing agreement, the DPA applies automatically to Aduvera's processing of Customer Personal Data on Customer's behalf.

Aduvera maintains a Business Associate Agreement with Google Cloud for eligible Google Cloud services used in Aduvera's HIPAA-covered workflows. This upstream BAA supports Aduvera's HIPAA compliance posture, but does not replace the BAA between Aduvera and Customer where such BAA is required. HIPAA compliance also depends on Customer's configuration, user permissions, workforce practices, access controls, minimum-necessary use, and other operational safeguards.

Some evidence-search functionality may retrieve public biomedical, regulatory, or scientific materials from third-party or public-source services outside Aduvera's hosted environment. Evidence-search features are intended for general clinical research and non-identifying queries unless Aduvera expressly designates the workflow as suitable for PHI. Customer is responsible for ensuring that users do not submit identifiable patient information into workflows not approved for PHI.

If there is a conflict between these Terms and the DPA or BAA, the DPA or BAA controls for the subject matter it covers.

Paid plans, if offered, will be described in an Order Form, pricing page, or checkout flow. Unless a different billing cadence is stated, subscriptions renew automatically for successive billing periods until canceled.

When Aduvera uses a merchant of record or reseller, including Polar or a similar checkout provider, that merchant of record may process payment, collect taxes, handle invoicing, and present additional checkout terms, billing policies, or refund terms. Those checkout terms apply alongside these Terms to the extent relevant to payment handling.

Unless an Order Form or checkout page states a different billing cadence, fees are billed in advance and exclude taxes. Aduvera offers a 14-day full-refund window for every payment, including initial purchases and renewal charges. You may cancel renewal at any time, with cancellation taking effect at the end of the current paid term.

Additional details about refunds, duplicate charges, and merchant-of-record billing flows are described in Aduvera's Refund Policy.

Aduvera retains all rights in the service, software, documentation, branding, and related materials, except for rights customers retain in their own data and outputs under applicable law and contract. Third-party articles, abstracts, labels, and other source materials retrieved through the evidence workflow remain subject to their own ownership, license, and access restrictions.

If you provide suggestions, comments, or feedback, Aduvera may use them without restriction or obligation.

Each party will protect the other party's confidential information using reasonable care and may use it only to perform under the applicable agreement, exercise rights, or comply with law. Confidential information does not include information that is public through no breach, independently developed, or rightfully received without confidentiality limits.

Aduvera may suspend or limit access if reasonably necessary to protect the service, comply with law, investigate suspected abuse, prevent harm, or address security risk. Either party may terminate the relationship as provided in an Order Form or, if there is no Order Form, by discontinuing use or providing notice. On termination, Aduvera will handle customer data under the applicable contract and documented retention/deletion policy.

Except as expressly stated in a written agreement, the service is provided on an "as-is" and "as-available" basis. Aduvera does not guarantee uninterrupted operation, uninterrupted availability, error-free outputs, or suitability for a particular legal, clinical, regulatory, coding, reimbursement, or procurement purpose.

Aduvera is not responsible for third-party source content, journal access restrictions, publisher corrections, withdrawn articles, public-database outages, or changes to external guideline and regulatory websites.

To the maximum extent permitted by law, neither party will be liable for indirect, incidental, special, consequential, exemplary, or punitive damages, or for lost profits, revenue, goodwill, or business interruption arising from or related to the service, even if advised of the possibility of those damages.

To the maximum extent permitted by law, Aduvera's aggregate liability under these Terms will not exceed the amounts paid by the customer to Aduvera for the service during the 12 months before the event giving rise to the claim, except to the extent a separate written agreement or mandatory law provides otherwise.

You will defend and indemnify Aduvera from third-party claims arising out of your unlawful data submission, your violation of these Terms, your misuse of evidence or literature outputs, or your violation of applicable law or third-party rights, except to the extent the claim results from Aduvera's breach of the applicable agreement.

Aduvera may update these Terms from time to time. Updated Terms become effective when posted, unless a later effective date is stated. If a change is material, Aduvera may require renewed acceptance before further use of the service.

Contract, legal, procurement, and workflow-review questions may be sent to legal [at] aduvera.ai.